Phase 4 Metabolic Syndrome Clinical Trials
9 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–9 of 9 trials
Recruiting
Phase 4
Impact GLP-1 Agonists Following Bariatric
Diabetes MellitusMetabolic SyndromeHypertension+2 more
University of Missouri-Columbia150 enrolled1 locationNCT06132477
Recruiting
Phase 4
Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
Metabolic Syndrome
University Medical Center, Kazakhstan220 enrolled1 locationNCT06410352
Recruiting
Phase 4
Extended-Release Tacrolimus Following Liver Transplantation
Cardiovascular DiseasesMetabolic SyndromeLiver Transplant; Complications+2 more
University of Alberta94 enrolled1 locationNCT05242315
Recruiting
Phase 4
Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
Metabolic SyndromeHIV InfectionAntiretroviral Treatment
Instituto Mexicano del Seguro Social124 enrolled1 locationNCT07031063
Recruiting
Phase 4
Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
Metabolic Syndrome
University of Virginia80 enrolled1 locationNCT04575844
Recruiting
Phase 4
High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
Metabolic SyndromeDyslipidemiasCoronary Artery Calcification
Samsung Medical Center6,000 enrolled1 locationNCT05845424
Active
Phase 4
The effect of Pioglitazone on Cardiovascular and Psychiatric status of non-Diabetic Metabolic Syndrome Patients
Metabolic SyndromeMental health screening indicators
Osvah Pharmaceutical Company140 enrolled1 locationACTRN12611000351910
Completed
Phase 3Phase 4
CoQ10 treatment in inadequately treated hypertensive patients with the metabolic syndrome.
HypertensionThe Metabolic Syndrome
Canterbury Health Laboratories30 enrolled1 locationACTRN12611000241932
Not Yet Recruiting
Phase 4
Does Caralluma fimbriata extract (Slimaluma) reduce the risk factors of metabolic syndrome in overweight and obese adults?
Prevention of metabolic syndrome
Victoria University50 enrolled1 locationACTRN12610000289011